Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma

article OA: closed CC0 ⤵ 37 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated the utility of the CA125 biomarker in distinguishing between uterine adenomyosis and uterine myoma to aid in their differential diagnosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis CA-125 Antigen Leiomyoma Membrane Proteins Uterine Neoplasms Adenomyosis Adenomyosis Adult Biomarkers Biomarkers CA-125 Antigen Diagnosis, Differential Female Humans Leiomyoma Leiomyoma Membrane Proteins Middle Aged Retrospective Studies ROC Curve

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (37)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:18:04.362919+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK